Clinical Significance of Nutrition and Inflammation in Esophageal Cancer Patients with Surgery: A Meta-Analysis

References

• Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J, Wei W, Inoue M, Tanaka H. Epidemiology of esophageal cancer in Japan and China. J Epidemiol. 2013;23(4):233–42. doi:10.2188/jea.je20120162
   PubMed Web of Science ®Google Scholar
• Ohashi S, Miyamoto S, Kikuchi O, Goto T, Amanuma Y, Muto M. Recent advances from basic and clinical studies of esophageal squamous cell carcinoma. Gastroenterology. 2015;149(7):1700–15. doi:10.1053/j.gastro.2015.08.054
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Wang P-y, Chen X-k, Liu Q, Xu L, Zhang R-x, Liu X-b, Li Y. Application of four nutritional risk indexes in perioperative management for esophageal cancer patients. J Cancer Res Clin Oncol. 2021;147(10):3099. doi:10.1007/s00432-021-03585-8
   PubMed Web of Science ®Google Scholar
• Bouillanne O, Morineau G, Dupont C, Coulombel I, Vincent J-P, Nicolis I, Benazeth S, Cynober L, Aussel C. Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005;82(4):777–83. doi:10.1093/ajcn/82.4.777
   PubMed Web of Science ®Google Scholar
• Hirahara N, Matsubara T, Fujii Y, Kaji S, Hyakudomi R, Yamamoto T, Uchida Y, Miyazaki Y, Ishitobi K, Kawabata Y, et al. Preoperative geriatric nutritional risk index is a useful prognostic indicator in elderly patients with gastric cancer. Oncotarget. 2020;11(24):2345–56. doi:10.18632/oncotarget.27635
   PubMedGoogle Scholar
• Lidoriki I, Schizas D, Frountzas M, Machairas N, Prodromidou A, Kapelouzou A, Karavokyros I, Pikoulis E, Kales S, Liakakos T, et al. GNRI as a prognostic factor for outcomes in cancer patients: a systematic review of the literature. Nutr Cancer. 2021;73(3):391–403. doi:10.1080/01635581.2020.1756350
   PubMed Web of Science ®Google Scholar
• Bo Y, Wang K, Liu Y, You J, Cui H, Zhu Y, Lu Q, Yuan L. The geriatric nutritional risk index predicts survival in elderly esophageal squamous cell carcinoma patients with radiotherapy. PLoS One. 2016;11(5):e0155903. doi:10.1371/journal.pone.0155903
   PubMed Web of Science ®Google Scholar
• Xu H-J, Ma Y, Deng F, Ju W-B, Sun X-Y, Wang H. The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis. Onco Targets Ther. 2017;10:3059–70. doi:10.2147/OTT.S137002
   PubMed Web of Science ®Google Scholar
• Wu J, Tan W, Chen L, Huang Z, Mai S. Clinicopathologic and prognostic significance of C-reactive protein/albumin ratio in patients with solid tumors: an updated systemic review and meta-analysis. Oncotarget. 2018;9(17):13934–47. doi:10.18632/oncotarget.24172
   PubMedGoogle Scholar
• Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K. Prognostic significance of the preoperative ratio of C-reactive protein to albumin in patients with colorectal cancer. Anticancer Res. 2016;36(3):995–1001.
   PubMed Web of Science ®Google Scholar
• Hutton B, Salanti G, Caldwell D, Chaimani A, Schmid C, Cameron C, Ioannidis J, Straus S, Thorlund K, Jansen J, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777–84. doi:10.7326/M14-2385
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. doi:10.1007/s10654-010-9491-z
   PubMed Web of Science ®Google Scholar
• Higgins J, Thompson S, Deeks J, Altman D. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. doi:10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Yamana I, Takeno S, Shimaoka H, Yamashita K, Yamada T, Shiwaku H, Hashimoto T, Yamashita Y, Hasegawa S. Geriatric Nutritional Risk Index as a prognostic factor in patients with esophageal squamous cell carcinoma -retrospective cohort study. Int J Surg. 2018;56:44–8. doi:10.1016/j.ijsu.2018.03.052
   PubMed Web of Science ®Google Scholar
• Migita K, Matsumoto S, Wakatsuki K, Ito M, Kunishige T, Nakade H, Sho M. The prognostic significance of the geriatric nutritional risk index in patients with esophageal squamous cell carcinoma. Nutr Cancer. 2018;70(8):1237–45. doi:10.1080/01635581.2018.1512640
   PubMed Web of Science ®Google Scholar
• Kubo N, Sakurai K, Tamura T, Toyokawa T, Tanaka H, Muguruma K, Yashiro M, Ohira M. The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer. Esophagus. 2019;16(2):147–54. doi:10.1007/s10388-018-0644-6
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang L, Fang M, Li J, Song T, Zhan W, Xu H. Prognostic value of the Geriatric Nutritional Risk Index in patients exceeding 70 years old with esophageal squamous cell carcinoma. Nutr Cancer. 2020;72(4):620–6. doi:10.1080/01635581.2019.1650189
   PubMed Web of Science ®Google Scholar
• Peng H, Tan X. The prognostic significance of sarcopenia and the neutrophil-to-lymphocyte ratio in elderly patients with esophageal squamous cell carcinoma. Cancer Manag Res. 2021;13:3209–18. doi:10.2147/CMAR.S302274
   PubMed Web of Science ®Google Scholar
• Tan X, Peng H, Gu P, Chen M, Wang Y. Prognostic significance of the L3 skeletal muscle index and advanced lung cancer inflammation index in elderly patients with esophageal cancer. Cancer Manag Res. 2021;13:3133–43. doi:10.2147/CMAR.S304996
   PubMed Web of Science ®Google Scholar
• Hirahara N, Matsubara T, Fujii Y, Kaji S, Hyakudomi R, Yamamoto T, Uchida Y, Miyazaki Y, Ishitobi K, Kawabata Y, et al. Geriatric nutritional risk index as a prognostic marker of pTNM-stage I and II esophageal squamous cell carcinoma after curative resection. Oncotarget. 2020;11(29):2834–46. doi:10.18632/oncotarget.27670
   PubMedGoogle Scholar
• Jomrich G, Paireder M, Gleiss A, Kristo I, Harpain L, Schoppmann SF. Comparison of inflammation-based prognostic scores in a cohort of patients with resectable esophageal cancer. Gastroenterol Res Pract. 2017;2017:1–10. doi:10.1155/2017/1678584
   Web of Science ®Google Scholar
• Sakai M, Sohda M, Saito H, Ubukata Y, Nakazawa N, Kuriyama K, Hara K, Sano A, Ogata K, Yokobori T, et al. Comparative analysis of immunoinflammatory and nutritional measures in surgically resected esophageal cancer: a single-center retrospective study. In Vivo. 2020;34(2):881–7. doi:10.21873/invivo.11853
   PubMed Web of Science ®Google Scholar
• Ishibashi Y, Tsujimoto H, Einama T, Mochizuki S, Kouzu K, Nomura S, Ito N, Harada M, Sugasawa H, Shinto E, et al. Correlation between immunoinflammatory measures and periostin expression in esophageal squamous cell carcinoma: a single-center, retrospective cohort study. Ann Surg Oncol. 2021;28(2):1228–37. doi:10.1245/s10434-020-08765-3
   PubMed Web of Science ®Google Scholar
• Tamagawa H, Aoyama T, Tamagawa A, Komori K, Maezawa Y, Kano K, Murakawa M, Atsumi Y, Hara K, Kazama K, et al. Influence of the preoperative C-reactive protein-to-albumin ratio on survival and recurrence in patients with esophageal cancer. Anticancer Res. 2020;40(4):2365–71. doi:10.21873/anticanres.14205
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Miyata H, Sugimura K, Motoori M, Asukai K, Yanagimoto Y, Takahashi Y, Tomokuni A, Yamamoto K, Akita H, et al. Prognostic significance of sarcopenia and systemic inflammatory response in patients with esophageal cancer. Anticancer Res. 2019;39(1):449–58. doi:10.21873/anticanres.13133
   PubMed Web of Science ®Google Scholar
• Kunizaki M, Tominaga T, Wakata K, Miyazaki T, Matsumoto K, Sumida Y, Hidaka S, Yamasaki T, Yasutake T, Sawai T, et al. Clinical significance of the C-reactive protein-to-albumin ratio for the prognosis of patients with esophageal squamous cell carcinoma. Mol Clin Onc. 2017;8:370–4. doi:10.3892/mco.2017.1527
   PubMed Web of Science ®Google Scholar
• Otowa Y, Nakamura T, Yamamoto M, Kanaji S, Matsuda Y, Matsuda T, Oshikiri T, Sumi Y, Suzuki S, Kakeji Y, et al. C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer. Dis Esophagus. 2017;30(12):1–5. doi:10.1093/dote/dox107
   PubMed Web of Science ®Google Scholar
• Zhang H, Guo XW, Yin XX, Liu YC, Ji SJ. Nomogram-integrated C-reactive protein/albumin ratio predicts efficacy and prognosis in patients with thoracic esophageal squamous cell carcinoma receiving chemoradiotherapy. CMAR. 2019;11:9459–68. doi:10.2147/CMAR.S228113
   Google Scholar
• Yu X, Wen Y, Lin Y, Zhang X, Chen Y, Wang W, Wang G, Zhang L. The value of preoperative Glasgow prognostic score and the C-reactive protein to albumin ratio as prognostic factors for long-term survival in pathological T1N0 esophageal squamous cell carcinoma. J Cancer. 2018;9(5):807–15. doi:10.7150/jca.22755
   PubMed Web of Science ®Google Scholar
• Zhao Q, Chen S, Feng JF. A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: neutrophil lymphocyte ratio/albumin ratio. Oncotarget. 2017;8(61):103535–42. doi:10.18632/oncotarget.21989
   PubMedGoogle Scholar
• Xu X, Yu H, Hu W, Song Q, Mao W. A novel inflammation-based prognostic score, the C-reactive protein/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma. PLoS One. 2015;10(9):e0138657. doi:10.1371/journal.pone.0138657
   PubMed Web of Science ®Google Scholar
• Wei X-l, Wang F-h, Zhang D-s, Qiu M-z, Ren C, Jin Y, Zhou Y-x, Wang D-s, He M-m, Bai L, et al. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. BMC Cancer. 2015;15(1):350. doi:10.1186/s12885-015-1379-6
   PubMedGoogle Scholar
• Shao Y, Ning Z, Chen J, Geng Y, Gu W, et al. Prognostic nomogram integrated systemic inflammation score for patients with esophageal squamouscell carcinoma undergoing radical esophagectomy. Sci Rep. 2015;5:18811.
   PubMed Web of Science ®Google Scholar
• Schiessel DL, Baracos VE. Barriers to cancer nutrition therapy: excess catabolism of muscle and adipose tissues induced by tumour products and chemotherapy. Proc Nutr Soc. 2018;77(4):394–402. doi:10.1017/S0029665118000186
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Yagyu T, Uchinaka E, Miyatani K, Hanaki T, Kihara K, Matsunaga T, Yamamoto M, Tokuyasu N, Honjo S, et al. The prognostic significance of combined geriatric nutritional risk index and psoas muscle volume in older patients with pancreatic cancer. BMC Cancer. 2021;21(1):342. doi:10.1186/s12885-021-08094-y
   PubMed Web of Science ®Google Scholar
• Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69. doi:10.1186/1475-2891-9-69
   PubMed Web of Science ®Google Scholar
• Ullah N, Ma F-R, Han J, Liu X-L, Fu Y, Liu Y-T, Liang Y-L, Ouyang H, Li H-Y. Monomeric C-reactive protein regulates fibronectin mediated monocyte adhesion. Mol Immunol. 2020;117:122–30. doi:10.1016/j.molimm.2019.10.013
   PubMed Web of Science ®Google Scholar
• Zhong W, Zen Q, Tebo J, Schlottmann K, Coggeshall M, Mortensen RF. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling. J Immunol. 1998;161(5):2533–40.
   PubMed Web of Science ®Google Scholar
• Sugawara K, Yamashita H, Urabe M, Okumura Y, Yagi K, et al. Geriatric nutrition index influences survival outcomes in gastric carcinoma patients undergoing radical surgery. JPEN J Parenter Enteral Nutr. 2021;45(5):1042–51.
   PubMed Web of Science ®Google Scholar
• Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 2015;282(1821):20143085. doi:10.1098/rspb.2014.3085
   PubMed Web of Science ®Google Scholar
• Xie Q, Wang L, Zheng S. Prognostic and clinicopathological significance of C-reactive protein to albumin ratio in patients with pancreatic cancer: a meta-analysis. Dose Response. 2020;18(2):155932582093129. doi:10.1177/1559325820931290
   Web of Science ®Google Scholar
• Yu J, Liu H, Zeng X, Zhao Y, Jiang D, Lu H, Qian J. Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: a meta-analysis. PLoS One. 2021;16(4):e0250295. doi:10.1371/journal.pone.0250295
   PubMed Web of Science ®Google Scholar
• Huang H, Liu Q, Zhu L, Zhang Y, Lu X, Wu Y, Liu L. Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer. Sci Rep. 2019;9(1):3284. doi:10.1038/s41598-019-39150-0
   PubMed Web of Science ®Google Scholar
• Miyamoto T, Fujitani M, Fukuyama H, Hatanaka S, Koizumi Y, Kawabata A. The C-reactive protein/albumin ratio is useful for predicting short-term survival in cancer and noncancer patients. J Palliat Med. 2019;22(5):532–7. doi:10.1089/jpm.2018.0404
   PubMed Web of Science ®Google Scholar